These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 25583989

  • 1. A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction.
    Kuster DW, Govindan S, Springer TI, Martin JL, Finley NL, Sadayappan S.
    J Biol Chem; 2015 Feb 27; 290(9):5855-67. PubMed ID: 25583989
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Variable cardiac myosin binding protein-C expression in the myofilaments due to MYBPC3 mutations in hypertrophic cardiomyopathy.
    Parbhudayal RY, Garra AR, Götte MJW, Michels M, Pei J, Harakalova M, Asselbergs FW, van Rossum AC, van der Velden J, Kuster DWD.
    J Mol Cell Cardiol; 2018 Oct 27; 123():59-63. PubMed ID: 30170119
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction.
    De Lange WJ, Grimes AC, Hegge LF, Spring AM, Brost TM, Ralphe JC.
    J Gen Physiol; 2013 Sep 27; 142(3):241-55. PubMed ID: 23980194
    [Abstract] [Full Text] [Related]

  • 8. Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.
    Barefield D, Kumar M, Gorham J, Seidman JG, Seidman CE, de Tombe PP, Sadayappan S.
    J Mol Cell Cardiol; 2015 Feb 27; 79():234-43. PubMed ID: 25463273
    [Abstract] [Full Text] [Related]

  • 9. Localization of the binding site of the C-terminal domain of cardiac myosin-binding protein-C on the myosin rod.
    Flashman E, Watkins H, Redwood C.
    Biochem J; 2007 Jan 01; 401(1):97-102. PubMed ID: 16918501
    [Abstract] [Full Text] [Related]

  • 10. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
    Flavigny J, Souchet M, Sébillon P, Berrebi-Bertrand I, Hainque B, Mallet A, Bril A, Schwartz K, Carrier L.
    J Mol Biol; 1999 Nov 26; 294(2):443-56. PubMed ID: 10610770
    [Abstract] [Full Text] [Related]

  • 11. Contractile dysfunction irrespective of the mutant protein in human hypertrophic cardiomyopathy with normal systolic function.
    van Dijk SJ, Paalberends ER, Najafi A, Michels M, Sadayappan S, Carrier L, Boontje NM, Kuster DW, van Slegtenhorst M, Dooijes D, dos Remedios C, ten Cate FJ, Stienen GJ, van der Velden J.
    Circ Heart Fail; 2012 Jan 26; 5(1):36-46. PubMed ID: 22178992
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction.
    van Dijk SJ, Dooijes D, dos Remedios C, Michels M, Lamers JM, Winegrad S, Schlossarek S, Carrier L, ten Cate FJ, Stienen GJ, van der Velden J.
    Circulation; 2009 Mar 24; 119(11):1473-83. PubMed ID: 19273718
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.
    Flenner F, Geertz B, Reischmann-Düsener S, Weinberger F, Eschenhagen T, Carrier L, Friedrich FW.
    J Physiol; 2017 Jun 15; 595(12):3987-3999. PubMed ID: 28090637
    [Abstract] [Full Text] [Related]

  • 20. Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes.
    Monteiro da Rocha A, Guerrero-Serna G, Helms A, Luzod C, Mironov S, Russell M, Jalife J, Day SM, Smith GD, Herron TJ.
    J Mol Cell Cardiol; 2016 Oct 15; 99():197-206. PubMed ID: 27620334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.